Neuphoria Therapeutics Inc. NEUP
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.90M | -505.10K | 1.86M | -9.91M | -8.88M |
| Total Depreciation and Amortization | 165.70K | 165.70K | 165.80K | 165.80K | 165.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.73M | -808.90K | -4.98M | 4.55M | 3.46M |
| Change in Net Operating Assets | 222.50K | -2.19M | -3.49M | 1.40M | 1.67M |
| Cash from Operations | 1.21M | -3.34M | -6.44M | -3.79M | -3.59M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 600.00K | 14.66M | 3.25M | 304.70K |
| Repurchase of Common Stock | -600.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 600.00K | -600.00K | -- | -- | 400.00K |
| Cash from Financing | 0.00 | 0.00 | 14.66M | 3.25M | 704.70K |
| Foreign Exchange rate Adjustments | -789.00K | 527.10K | 295.40K | -19.50K | 49.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 424.90K | -2.81M | 8.52M | -560.50K | -2.83M |